64 results
8-K
EX-99.1
VXRT
Vaxart Inc
30 Apr 24
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
4:22pm
States alone.
Globally, norovirus has become the leading cause of pediatric gastroenteritis in health care settings in countries that have adopted
8-K
EX-10.1
VXRT
Vaxart Inc
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
Information Technology for Economic and Clinical Health Act of 2009, and the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care
8-K
EX-1.1
VXRT
Vaxart Inc
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm
device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) except for such failures … that imposes any obligation or liability by a governmental or regulatory authority under any Privacy Law.
-15-
(uu) Compliance with Health Care Laws
8-K
EX-99.1
ql4uu1tyf 2y
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm
8-K
EX-99.1
yv4avhl4z9 xv25
28 Jun 22
Other Events
5:09pm
8-K
EX-99.1
kvrcn hvo69
15 Feb 22
Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
4:02pm
8-K
EX-1.1
8q8li6irt8jesvdfu
15 Sep 21
Entry into a Material Definitive Agreement
9:47pm
8-K
EX-1.1
exs7f6yl
14 Oct 20
Entry into a Material Definitive Agreement
6:04am
S-3ASR
EX-1.2
fg2qhuy vircovx
8 Jul 20
Automatic shelf registration
8:50am